333 related articles for article (PubMed ID: 9613723)
1. Update on fetal transplantation: the Swedish experience.
Lindvall O
Mov Disord; 1998; 13 Suppl 1():83-7. PubMed ID: 9613723
[TBL] [Abstract][Full Text] [Related]
2. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
Kordower JH; Freeman TB; Chen EY; Mufson EJ; Sanberg PR; Hauser RA; Snow B; Olanow CW
Mov Disord; 1998 May; 13(3):383-93. PubMed ID: 9613726
[TBL] [Abstract][Full Text] [Related]
3. Neural transplantation: a hope for patients with Parkinson's disease.
Lindvall O
Neuroreport; 1997 Sep; 8(14):iii-x. PubMed ID: 9331903
[TBL] [Abstract][Full Text] [Related]
4. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.
Lindvall O; Sawle G; Widner H; Rothwell JC; Björklund A; Brooks D; Brundin P; Frackowiak R; Marsden CD; Odin P
Ann Neurol; 1994 Feb; 35(2):172-80. PubMed ID: 8109898
[TBL] [Abstract][Full Text] [Related]
5. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
Falkenstein G; Rosenthal C; Reum T; Morgenstern R; Döbrössy M; Nikkhah G
J Comp Neurol; 2009 Jul; 515(1):41-55. PubMed ID: 19399892
[TBL] [Abstract][Full Text] [Related]
6. [Long-term survival of fetal substantia nigra grafts in striatum of PD rats: an observation of tyrosine hydroxylase immunohistochemistry and western blot].
Yang H; Cai W; Zhang K
Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):13-5. PubMed ID: 10374499
[TBL] [Abstract][Full Text] [Related]
7. Neural transplantation in Parkinson's disease.
Lindvall O
Novartis Found Symp; 2000; 231():110-23; discussion 123-8, 145-7. PubMed ID: 11131534
[TBL] [Abstract][Full Text] [Related]
8. A sequential intrastriatal dopaminergic graft strategy in the rodent model for Parkinson's disease: implications for graft survival and targeting.
Baker KA; Purdy MB; Sadi D; Mukhida K; Mendez I
Cell Transplant; 2002; 11(3):185-93. PubMed ID: 12075984
[TBL] [Abstract][Full Text] [Related]
9. Autologous adrenal medullary, fetal mesencephalic, and fetal adrenal brain transplantation in Parkinson's disease: a long-term postoperative follow-up.
Madrazo I; Franco-Bourland R; Aguilera M; Ostrosky-Solis F; Madrazo M; Cuevas C; Catrejon H; Guizar-Zahagun G; Magallon E
J Neural Transplant Plast; 1991; 2(3-4):157-64. PubMed ID: 1782251
[TBL] [Abstract][Full Text] [Related]
10. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
[TBL] [Abstract][Full Text] [Related]
11. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J
Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602
[TBL] [Abstract][Full Text] [Related]
12. Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results.
Kirik D; Björklund A
Brain; 2005 Jul; 128(Pt 7):1478-9. PubMed ID: 15980119
[No Abstract] [Full Text] [Related]
13. Expanded mesencephalic precursors develop into grafts of densely packed dopaminergic neurons that reinnervate the surrounding striatum and induce functional responses in the striatal neurons.
Rodriguez-Pallares J; Parga JA; Rey P; Guerra MJ; Labandeira-Garcia JL
Synapse; 2005 Oct; 58(1):13-22. PubMed ID: 16037947
[TBL] [Abstract][Full Text] [Related]
14. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
Törnqvist N; Björklund L; Strömberg I
Exp Neurol; 2001 Jun; 169(2):329-39. PubMed ID: 11358446
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
Freed CR; Greene PE; Breeze RE; Tsai WY; DuMouchel W; Kao R; Dillon S; Winfield H; Culver S; Trojanowski JQ; Eidelberg D; Fahn S
N Engl J Med; 2001 Mar; 344(10):710-9. PubMed ID: 11236774
[TBL] [Abstract][Full Text] [Related]
16. An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality.
Sortwell CE; Collier TJ; Camargo MD; Pitzer MR
Exp Neurol; 2004 May; 187(1):58-64. PubMed ID: 15081588
[TBL] [Abstract][Full Text] [Related]
17. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease.
Marchionini DM; Collier TJ; Camargo M; McGuire S; Pitzer M; Sortwell CE
J Comp Neurol; 2003 Sep; 464(2):172-9. PubMed ID: 12898610
[TBL] [Abstract][Full Text] [Related]
18. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.
Carlsson T; Winkler C; Lundblad M; Cenci MA; Björklund A; Kirik D
Neurobiol Dis; 2006 Mar; 21(3):657-68. PubMed ID: 16256359
[TBL] [Abstract][Full Text] [Related]
19. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval.
Sortwell CE; Camargo MD; Pitzer MR; Gyawali S; Collier TJ
Exp Neurol; 2001 May; 169(1):23-9. PubMed ID: 11312554
[TBL] [Abstract][Full Text] [Related]
20. Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons.
Strömberg I; Törnqvist N; Johansson S; Bygdeman M; Almqvist PM
Microsc Res Tech; 2001 Sep; 54(5):287-97. PubMed ID: 11514985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
